WS #16779
Teva Pharmaceutical and Enlight Renewable Energy both reported strong third-quarter results, beating analyst expectations and raising full-year guidance. Teva's improved earnings and Enlight's 40% revenue growth highlight operational strength in their respective sectors, offering a counter-narrative to broader market weakness and providing opportunities in healthcare and renewable energy portfolios.
Healthcare & Renewable Energy Earnings
Teva Pharmaceutical and Enlight Renewable Energy both reported strong third-quarter results, beating analyst expectations and raising full-year guidance. Teva's improved earnings and Enlight's 40% revenue growth highlight operational strength in their respective sectors, offering a counter-narrative to broader market weakness and providing opportunities in healthcare and renewable energy portfolios.